28 research outputs found
Cardiac sarcoidosis and giant cell myocarditis after COVID-19 infection
Patients infected with SARS-CoV-2 have varying manifestations of cardiac involvement. We report four patients presenting with symptomatic cardiac sarcoidosis (CS) or giant cell myocarditis (GCM) 1-8 months after mild COVID-19. All patients received immunosuppressive therapy and improved gradually within the following months. The possible temporal association between the CS/GCM and COVID-19 infection might suggest that COVID-19 could be a trigger for granulomatous myocarditis.Peer reviewe
Gender and working conditions in the European Union
SIGLEAvailable from British Library Document Supply Centre-DSC:OP-EC/4769 / BLDSC - British Library Document Supply CentreGBUnited Kingdo